BridgeBio Pharma Prices Stock Offering to Raise $250M

Wednesday, 6 March 2024, 10:59

BridgeBio Pharma has announced the pricing of a stock offering to raise $250M in gross proceeds. The offering comprises 8.62M shares priced at $29 each. This move is aimed at raising capital to support the company's growth initiatives and strategic expansion plans.
LivaRava Finance Meta Image
BridgeBio Pharma Prices Stock Offering to Raise $250M

BridgeBio Pharma Announces Pricing of $250M Stock Offering

BridgeBio Pharma has announced the pricing of a stock offering to raise $250M in gross proceeds. The offering comprises 8.62M shares priced at $29 each.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe